What is the Size of the U.S. Alternate-Site Infusion Therapy Market?

As healthcare continues to prioritize affordability and patient-centered care, alternate-site infusion therapy has emerged as a transformative solution, offering both cost savings and the convenience of recovery in familiar settings.

Driven by heightened emphasis on cost-effectiveness and cost-containment, and the desire of patients to resume normal lifestyles and work activities while recovering from illness, the alternate-site infusion therapy sector continues to expand. In 2020, NHIA estimates that home and specialty infusion is a $19 billion industry made up of over 900 providers serving 3.2 million patients annually.

However, the overall contribution of home infusion therapy to the health care system is certainly much more significant. The cost of infusion therapy administered in the home or alternate-site care setting is far less than the cost of inpatient treatment